Tanya Hayden

Ms. Hayden was previously the Chief Operating Officer of Acer Therapeutics, where she was primarily responsible for supporting operational and commercial growth and effectiveness, as well as establishing, improving, and scaling the company’s executional operations. Zevra Therapeutics acquired Acer Therapeutics in November of 2023, after which Ms. Hayden transitioned to the role of Senior Vice President, Chief of Staff.

Prior to joining Acer, Ms. Hayden spent 20 years at Lonza (formerly Bend Research/Capsugel) and held various roles, with increasing responsibilities across business unit planning and strategic projects, operational excellence, clinical and commercial contract manufacturing, and program management.

Throughout her career, Ms. Hayden has had the opportunity to lead internal cross-functional teams to introduce new capabilities and improve performance, as well as collaborate with external partners to advance new products to the market.

Ms. Hayden received her B.S. in chemistry from Gonzaga University.